NO20050979L - Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase - Google Patents

Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase

Info

Publication number
NO20050979L
NO20050979L NO20050979A NO20050979A NO20050979L NO 20050979 L NO20050979 L NO 20050979L NO 20050979 A NO20050979 A NO 20050979A NO 20050979 A NO20050979 A NO 20050979A NO 20050979 L NO20050979 L NO 20050979L
Authority
NO
Norway
Prior art keywords
crcv
coronavirus
hemagglutinin
polymerase
esterase
Prior art date
Application number
NO20050979A
Other languages
English (en)
Other versions
NO20050979D0 (no
Inventor
John Brownlie
Victoria Jane Chalker
Kerstin Erles
Original Assignee
Royal Veterinary College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Veterinary College filed Critical Royal Veterinary College
Publication of NO20050979D0 publication Critical patent/NO20050979D0/no
Publication of NO20050979L publication Critical patent/NO20050979L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Abstract

Sammendrag: Et caninus respiratorisk coronavirus (CRCV) som er tilstede i luftveiene hos hunder med caninus infeksiøs respiratorisk sykdom, og som har et lavt nivå av homologi med det enteriske caninus coronaviruset, men som har et høyt nivå av homologi med alle bovine coronavirus stammer (for eksempel Quebec og LY 138) og med humant coronavirus stamme OC43. CRCV-toppen, polymerase og hemagglutinin/esterase cDNA og protein partielle sekvenser er listet i figur (I) til (4), (13) og (14).
NO20050979A 2002-07-27 2005-02-23 Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase NO20050979L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0217434.0A GB0217434D0 (en) 2002-07-27 2002-07-27 Biological material
PCT/GB2003/002832 WO2004011651A1 (en) 2002-07-27 2003-07-01 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase

Publications (2)

Publication Number Publication Date
NO20050979D0 NO20050979D0 (no) 2005-02-23
NO20050979L true NO20050979L (no) 2005-04-25

Family

ID=9941223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050979A NO20050979L (no) 2002-07-27 2005-02-23 Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase

Country Status (17)

Country Link
US (2) US7776340B2 (no)
EP (2) EP2182066A3 (no)
JP (1) JP4644486B2 (no)
AT (1) ATE491793T1 (no)
AU (1) AU2003244822B2 (no)
CA (2) CA2727782C (no)
CY (1) CY1111655T1 (no)
DE (1) DE60335374D1 (no)
DK (1) DK1525313T3 (no)
ES (1) ES2384445T3 (no)
GB (1) GB0217434D0 (no)
MX (1) MXPA05001098A (no)
NO (1) NO20050979L (no)
NZ (2) NZ556442A (no)
PT (1) PT1525313E (no)
SI (1) SI1525313T1 (no)
WO (1) WO2004011651A1 (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US20040121313A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in organs for transplantation
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
JP2006516193A (ja) 2002-12-06 2006-06-29 アイシス・ファーマシューティカルス・インコーポレーテッド ヒトおよび動物における病原体の迅速な同定方法
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US9023366B2 (en) 2003-07-01 2015-05-05 The Royal Veterinary College Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
GB0315323D0 (en) 2003-07-01 2003-08-06 Royal Veterinary College Vaccine composition
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US7956175B2 (en) 2003-09-11 2011-06-07 Ibis Biosciences, Inc. Compositions for use in identification of bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
WO2006076007A2 (en) * 2004-04-22 2006-07-20 Vanderbilt University Methods of detecting coronavirus infections
CA2567839C (en) 2004-05-24 2011-06-28 Isis Pharmaceuticals, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
WO2006135400A2 (en) 2004-08-24 2006-12-21 Isis Pharmaceuticals, Inc. Methods for rapid identification of recombinant organisms
US8182992B2 (en) 2005-03-03 2012-05-22 Ibis Biosciences, Inc. Compositions for use in identification of adventitious viruses
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
AU2006272776B2 (en) 2005-07-21 2012-01-19 Ibis Biosciences, Inc. Methods for rapid identification and quantitation of nucleic acid variants
CA2621320C (en) 2005-10-07 2016-05-24 Pfizer Products Inc. Vaccines and methods to treat canine influenza
ES2355702T3 (es) * 2005-10-26 2011-03-30 Canio Buonavoglia Coronavirus canino pantrópico.
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
EP2064332B1 (en) 2006-09-14 2012-07-18 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
WO2008104002A2 (en) 2007-02-23 2008-08-28 Ibis Biosciences, Inc. Methods for rapid forensic dna analysis
US9598724B2 (en) 2007-06-01 2017-03-21 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
EP2344893B1 (en) 2008-09-16 2014-10-15 Ibis Biosciences, Inc. Microplate handling systems and methods
EP2349549B1 (en) 2008-09-16 2012-07-18 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, and system
EP2347254A2 (en) 2008-09-16 2011-07-27 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
EP2396803A4 (en) 2009-02-12 2016-10-26 Ibis Biosciences Inc IONIZATION PROBE ASSEMBLIES
US8950604B2 (en) 2009-07-17 2015-02-10 Ibis Biosciences, Inc. Lift and mount apparatus
WO2011008972A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Systems for bioagent identification
EP3225695A1 (en) 2009-10-15 2017-10-04 Ibis Biosciences, Inc. Multiple displacement amplification
KR20130112950A (ko) * 2011-02-04 2013-10-14 조에티스 엘엘씨 개 호흡기 복합 질환용 조성물
CA2826060C (en) * 2011-02-04 2019-06-18 Zoetis Llc Immunogenic bordetella bronchiseptica compositions
ITMI20111182A1 (it) * 2011-06-28 2012-12-29 Canio Buonavoglia Vaccino per coronavirus canino
WO2013181086A1 (en) 2012-05-31 2013-12-05 Zoetis Llc Vaccination with canine respiratory coronavirus for protection against b. bronchiseptica infections
CN105803112A (zh) * 2016-03-28 2016-07-27 中国人民解放军成都军区疾病预防控制中心 用于检测犬细小病毒的引物、探针和试剂盒及检测方法
CN108318685A (zh) * 2018-05-04 2018-07-24 广州敏捷生物技术有限公司 用于检测犬冠状病毒抗原的免疫荧光层析检测卡与制备方法
CN111254155A (zh) * 2020-01-25 2020-06-09 王跃驹 一种植物作为宿主表达病毒疫苗的方法
WO2021159648A1 (zh) * 2020-02-10 2021-08-19 中国科学院微生物研究所 一种β冠状病毒抗原、其制备方法和应用
CN112094953B (zh) * 2020-10-30 2022-11-11 内蒙古农业大学 用于同时检测牛病毒性腹泻病毒、牛轮状病毒和牛冠状病毒的试剂盒及引物和探针
US11175293B1 (en) 2021-01-04 2021-11-16 University Of Utah Research Foundation Rapid assay for detection of SARS-CoV-2 antibodies
CA3106787A1 (en) * 2021-01-22 2022-07-22 Amphotericin B Technologies Inc. Use of amphotericin b in the treatment of coronavirus diseases
CN116854784B (zh) * 2023-09-05 2023-11-17 北京纳百生物科技有限公司 犬冠状病毒n蛋白抗原截短体及其应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567043A (en) * 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US5672350A (en) 1989-08-22 1997-09-30 Veterinary Infectious Disease Organization Recombinant bovine coronavirus E2 and E3 polypeptides and vaccines
NZ240558A (en) 1990-11-14 1994-11-25 Smithkline Beecham Corp Recombinant feline coronavirus s proteins useful in diagnosis and vaccination against feline peritonitis virus disease
US6057436A (en) * 1990-11-14 2000-05-02 Pfizer Inc. Canine coronavirus S gene and uses therefor
US6372224B1 (en) 1990-11-14 2002-04-16 Pfizer Inc. Canine coronavirus S gene and uses therefor
ES2213743T3 (es) * 1991-04-25 2004-09-01 Akzo Nobel N.V. Vacuna de subunidad de coronavirus canino.
ES2182827T3 (es) * 1992-05-08 2003-03-16 Pfizer Gen del virus corona canino y usos del mismo.
US5750112A (en) 1993-02-26 1998-05-12 Solvay Animal Health, Inc. Canine coronavirus vaccine from feline enteric coronavirus
ES2224172T3 (es) 1995-06-12 2005-03-01 Kansas State University Research Foundation Vacuna multivalente de coronavirus bovino y metodo para tratar la infeccion por coronavirus bovino.
JP2002501365A (ja) 1996-10-11 2002-01-15 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド 組織型プラスミノーゲンアクチベーターの脳関連インヒビター
WO1999025838A1 (en) * 1997-11-14 1999-05-27 University Of Georgia Research Foundation, Inc. Compositions and methods to prevent turkey enteritis
US6974577B2 (en) * 2001-02-04 2005-12-13 Novartris Ag Inactivated bovine scours vaccines, processes and method of preventing bovine scours

Also Published As

Publication number Publication date
EP1525313B1 (en) 2010-12-15
EP2182066A3 (en) 2010-08-11
JP2005533513A (ja) 2005-11-10
US20090081780A1 (en) 2009-03-26
SI1525313T1 (sl) 2011-03-31
GB0217434D0 (en) 2002-09-04
US7981427B2 (en) 2011-07-19
US20070248616A1 (en) 2007-10-25
CA2727782A1 (en) 2004-02-05
AU2003244822B2 (en) 2009-01-29
ES2384445T3 (es) 2012-07-05
NZ537778A (en) 2008-04-30
DK1525313T3 (da) 2011-03-14
CY1111655T1 (el) 2015-10-07
AU2003244822A1 (en) 2004-02-16
EP1525313A1 (en) 2005-04-27
NO20050979D0 (no) 2005-02-23
US7776340B2 (en) 2010-08-17
CA2727782C (en) 2016-10-11
JP4644486B2 (ja) 2011-03-02
ATE491793T1 (de) 2011-01-15
WO2004011651A1 (en) 2004-02-05
DE60335374D1 (en) 2011-01-27
EP2182066A2 (en) 2010-05-05
CA2492333A1 (en) 2004-02-05
MXPA05001098A (es) 2005-09-08
NZ556442A (en) 2009-03-31
CA2492333C (en) 2013-08-20
PT1525313E (pt) 2011-03-14

Similar Documents

Publication Publication Date Title
NO20050979L (no) Caninus respiratorisk coronavirus (CRCV) spike protein, polymerase og hemagglutinin/esterase
ES2524458T3 (es) DNasa para el tratamiento de la subfertilidad masculina
NO20074412L (no) Bruddresistente administrasjonsformer med forsinket frigiving
BRPI0408807A (pt) sistema de fixação de fratura de osso com suporte de superfìcie articular e subcondral
SI1917987T1 (sl) Izpiralno/izsesovalni sistem
UA94717C2 (ru) Модифицированный вирус гриппа, предназначенный для мониторинга и повышения эффективности вакцины
WO2006110738A3 (en) Active compression screw system and method for using the same
CR8012A (es) Clavo endomedular destinado al tratamiento de fracturas de femur proximal
ATE519447T1 (de) Aufbau mit hydroxylierter oberfläche
WO2007109767A3 (en) Bone anchor installer and method of use
BRPI0509047B8 (pt) Implante dentário, e, combinação de um implante e um apoio conectável ao dito implante
ATE392859T1 (de) Wirbelsäulen-osteosynthesesystem
ATE385747T1 (de) Dentalmedizinisches oder chirurgisches handstück
WO2008118524A3 (en) Instrumented linkage system
SG160327A1 (en) Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
HUP0302265A2 (hu) Rekombináns Newcastle-betegségvírus nukleoprotein-mutánsa markervakcinaként alkalmazva
ATE392196T1 (de) Chirurgisches instrument zum entfernen eines zwischenwirbelimplantats
AU2003289631A1 (en) A recombinant adenovirus relating gene vaccine used to therapy and prevent alzheimers disease, and use thereof
WO2005110493A3 (en) Methods for delivering mbd peptide-linked agent into cells under conditions of cellular stress
DE602007001467D1 (de) Therapeutische Zubereitung von hochreinem FVIIa und Verfahren zu dessen Gewinnung
WO2008029142A3 (en) A bone plate for fixation to a patient's vertebrae
MX2009003976A (es) Taladro para el uso en odontologia y con inercia modulada.
DE602004015772D1 (de) Ein matrizenband
ATE346552T1 (de) Implantatsystem
BR9808226A (pt) Coronavìrus respiratório bovino como uma vacina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application